20 completed, 6 withdrawn, 4 terminated, 1 unknown. 31 Phase 1, 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 31 | Completed 20, Withdrawn 6, Terminated 4, Unknown 1 |
| Phase 2 | 6 | Completed 2, Terminated 2, Unknown 1, Withdrawn 1 |
Follow Immunoenzyme Techniques: new trials by email Literature Review of Immunoenzyme Techniques trials Research Report on Immunoenzyme Techniques
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ex Vivo-Expanded HER2-Specific T Cells and Cyclophosphamide After Vaccine Therapy in Treating Patients With HER2-Positive Stage IV Breast Cancer HER-2/neu peptide vaccine, cyclophosphamide, ex vivo-expanded HER2-specific T cells - HER2-positive Breast Cancer, Male Breast Cancer | Phase 1 | Withdrawn | University of Washington | 2012-06-01 | 2013-05-17 | |
| Vaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic Cancer laboratory biomarker analysis, enzyme-linked immunosorbent assay, flow cytometry - Recurrent Colon Cancer, Recurrent Gastric Cancer | Phase 1 | Completed | City of Hope Medical Center | 12 | 2011-12-22 | 2026-10-19 |
| ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme temozolomide, veliparib, DNA methylation analysis - Brain and Central Nervous System Tumors | Phase 1 | Completed | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 24 | 2009-07-13 | 2018-06-27 |
| Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma epirubicin hydrochloride, ifosfamide, sorafenib tosylate - Sarcoma | Phase 1 | Completed | OHSU Knight Cancer Institute | 18 | 2009-02-01 | 2018-09-07 |
| Laboratory-Treated T Cells and Ipilimumab in Treating Patients With Metastatic Melanoma ipilimumab, cyclophosphamide, biopsy - Recurrent Melanoma, Stage IV Melanoma | Phase 1 / Phase 2 | Completed | Fred Hutchinson Cancer Center | 10 | 2009-02-01 | 2017-04-19 |
| Stereotactic Radiosurgery and Erlotinib in Treating Patients With Non-Small Cell Lung Cancer and Brain Metastases erlotinib hydrochloride, immunoenzyme technique, laboratory biomarker analysis - Lung Cancer, Metastatic Cancer | Phase 1 | Withdrawn | University of California, San Francisco | 2009-01-01 | 2012-10-04 | |
| Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer cyclosporine, mycophenolate mofetil, pentostatin - Chronic Myeloproliferative Disorders, Leukemia | Phase 1 / Phase 2 | Withdrawn | University of Nebraska | 2008-09-01 | 2023-08-14 | |
| Hydroxychloroquine and Temozolomide in Treating Patients With Metastatic or Unresectable Solid Tumors hydroxychloroquine, temozolomide, TdT-mediated dUTP nick end labeling assay - Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Completed | Abramson Cancer Center at Penn Medicine | 38 | 2008-06-01 | 2016-02-18 |
| PEG-Interferon Alfa-2b and Sorafenib in Treating Patients With Unresectable or Metastatic Kidney Cancer PEG-interferon alfa-2b, Sorafenib, gene expression analysis - Kidney Cancer | Phase 1 | Terminated | Thomas Olencki | 1 | 2008-02-01 | 2015-06-08 |
| Vandetanib and Temozolomide in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By Surgery temozolomide, vandetanib, immunoenzyme technique - Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Withdrawn | Mayo Clinic | 2008-01-01 | 2014-03-10 | |
| Vaccine Therapy in Treating Patients With Recurrent B-Cell Lymphoma plasmid DNA vaccine therapy, flow cytometry, immunoenzyme technique - Lymphoma | Phase 1 | Completed | Memorial Sloan Kettering Cancer Center | 8 | 2007-10-01 | 2015-11-17 |
| KX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to Treatment Src kinase inhibitor KX2-391, immunoenzyme technique, pharmacological study - Lymphoma, Lymphoproliferative Disorder | Phase 1 | Completed | Roswell Park Cancer Institute | 7 | 2007-10-01 | 2011-03-02 |
| SB939 in Treating Patients With Locally Advanced or Metastatic Solid Tumors HDAC inhibitor SB939, immunoenzyme technique, immunohistochemistry staining method - Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Completed | NCIC Clinical Trials Group | 39 | 2007-09-14 | 2023-08-04 |
| Radiation Therapy and Ammonium Tetrathiomolybdate in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer ammonium tetrathiomolybdate, immunoenzyme technique, laboratory biomarker analysis - Lung Cancer | Phase 1 | Withdrawn | Roswell Park Cancer Institute | 2007-05-01 | 2022-10-03 | |
| Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer recombinant interleukin-7, gene expression analysis, polymerase chain reaction - Kidney Cancer, Melanoma (Skin) | Phase 1 | Terminated | Cytheris SA | 9 | 2007-05-01 | 2012-10-18 |
| Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the Prostate defined green tea catechin extract, placebo, immunohistochemistry staining method - Adenocarcinoma of the Prostate, Stage I Prostate Cancer | Phase 1 | Completed | National Cancer Institute (NCI) | 50 | 2007-03-01 | 2014-10-08 |
| Studying Genes in Blood and Lung Fluid Samples From Patients With Chronic Obstructive Pulmonary Disease With or Without a Previous Diagnosis of Lung Cancer or With Asthma Treated With Budesonide and Formoterol budesonide/formoterol fumarate dihydrate inhalation aerosol, DNA methylation analysis, comparative genomic hybridization - Lung Cancer, Precancerous Condition | Phase 1 | Completed | British Columbia Cancer Agency | 30 | 2007-01-01 | 2012-03-09 |
| Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma WT-1 analog peptide vaccine, incomplete Freund's adjuvant, sargramostim - Leukemia, Lung Cancer | Phase 1 | Completed | Memorial Sloan Kettering Cancer Center | 22 | 2006-10-01 | 2016-03-02 |
| AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid Tumors AEG35156, docetaxel, protein expression analysis - Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Completed | NCIC Clinical Trials Group | 27 | 2006-07-27 | 2023-08-04 |
| Vaccine Therapy, Incomplete Freund's Adjuvant, and GM-CSF in Treating Patients With HIV E1M184V peptide vaccine, incomplete Freund's adjuvant, sargramostim - Nonneoplastic Condition | Phase 1 | Completed | National Institutes of Health Clinical Center (CC) | 40 | 2006-07-01 | 2012-05-02 |
Showing 20 of 31. Sign in to see all of them.
Carcinoma, Non-Small-Cell Lung (6) · Lung Neoplasms (6) · Breast Neoplasms (4) · Lymphoma, B-Cell, Marginal Zone (4) · Lymphoma, Follicular (4) · Lymphoma, Mantle-Cell (4) · Lymphoma, Non-Hodgkin (4) · Melanoma (4) · Carcinoma, Ovarian Epithelial (3) · Congenital Abnormalities (3) · Leukemia, Lymphocytic, Chronic, B-Cell (3) · Lymphoma (3) · Lymphoma, Large B-Cell, Diffuse (3) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (3) · Blast Crisis (2)
City of Hope Medical Center (3) · University of Washington (3) · Mayo Clinic (2) · Memorial Sloan Kettering Cancer Center (2) · NCIC Clinical Trials Group (2) · Roswell Park Cancer Institute (2) · University of California, Davis (2) · Abramson Cancer Center at Penn Medicine (1) · British Columbia Cancer Agency (1) · Case Comprehensive Cancer Center (1) · Centre Hospitalier Universitaire Vaudois (1) · Cytheris SA (1) · Fred Hutchinson Cancer Center (1) · National Cancer Institute (NCI) (1) · National Institutes of Health Clinical Center (CC) (1)
United States (23) · Canada (3) · Switzerland (1)
Angela Davies, MD (2) · Alan N. Houghton, MD (1) · Alex A. Adjei, MD, PhD (1) · Andrew D. Zelenetz, MD, PhD (1) · Aude Chapuis (1) · Christopher W. Ryan, MD (1) · Claire F. Verschraegen, MD (1) · Francois Luthi, MD (1) · Frederick Ahmann (1) · Gerald Batist, MD (1) · Hillard M. Lazarus, MD (1) · James L. Rubenstein, MD, PhD (1) · Jeffrey A. Sosman, MD (1) · Kathleen M. Wyvill, BSN, RN (1) · Larry Kleinberg, MD (1)
PMID 18090584, PMID 20400682, PMID 21285985, PMID 22044694, PMID 24386300, PMID 24987057, PMID 27269940, PMID 28679643, PMID 36326756
K12CA076930 (1), N01CN35158 (1), P01CA023766 (1), P30CA008748 (1), P30CA015083 (1), P30CA033572 (1), P30CA036727 (1), P30CA043703 (1), P30CA069533 (1), P30CA093373 (1), U01CA062475 (1)